Mobile Health Innovative Solutions v. Google — Dismissed With Prejudice in 261 Days
Mobile Health Innovative Solutions, LLC filed suit against Google, LLC in the Eastern District of Texas, asserting US11468984B2 against the Google Pixel Watch line. The parties jointly stipulated to dismissal with prejudice in under nine months, with each side bearing its own costs and fees.
NPE asserts wearable health patent against Google Pixel Watch in Texas
On June 11, 2024, Mobile Health Innovative Solutions, LLC filed a patent infringement complaint against Google, LLC in the Eastern District of Texas before Judge Rodney Gilstrap, one of the country’s most active patent judges. The asserted patent, US11468984B2 (application no. US16/850984), relates to wearable health monitoring technology, and the accused products were identified as Google Pixel Watches, specifically referencing the Google Pixel Watch 2. The plaintiff was represented by Garteiser Honea PLLC and Sinergia Technology Law Group, PLLC — both boutique IP litigation firms with NPE plaintiff experience.
The case closed on February 27, 2025, after just 261 days, through a Joint Stipulation of Dismissal filed as Dkt. No. 40. Critically, plaintiff’s claims were dismissed with prejudice, meaning Mobile Health cannot re-assert the same patent claims against Google based on conduct that was or could have been raised in this suit. Google’s counterclaims and defenses were dismissed without prejudice, leaving Google free to revive invalidity or other defenses in a future proceeding. Each party bears its own costs and fees, consistent with a negotiated resolution rather than a litigation win.
A dismissal with prejudice at this speed — before any Markman hearing or substantive motion practice on the merits — strongly suggests the parties reached a private settlement or licensing arrangement, though the public record is silent on financial terms. The asymmetric dismissal structure (plaintiff with prejudice, defendant without prejudice) is commercially significant: Google retains full optionality to challenge the patent’s validity in the future, while Mobile Health’s enforcement path against Google on US11468984B2 is permanently closed. The speed and stipulated nature of the resolution are consistent with early-stage licensing negotiations common in NPE-versus-large-tech litigation in the Eastern District of Texas.
Filing to Case Dismissed in 261 days
261 days — resolved faster than the E.D. Texas median for patent cases before Judge Gilstrap
Dismissed with prejudice: what the joint stipulation means for both parties
Rule 41 joint stipulation: what ‘with prejudice’ locks in
Under Federal Rule of Civil Procedure 41, a dismissal with prejudice operates as a final adjudication on the merits. Mobile Health’s decision to stipulate to this form of dismissal permanently extinguishes its right to re-sue Google on any claim it raised or could have raised in this action under US11468984B2. This is the most plaintiff-restrictive form of voluntary dismissal, and its presence in a joint stipulation typically signals a negotiated resolution rather than a unilateral plaintiff withdrawal.
Rule 41 — with prejudiceMobile Health’s enforcement path against Google is permanently closed
By agreeing to dismiss with prejudice, Mobile Health Innovative Solutions surrenders all future infringement claims against Google relating to US11468984B2 for conduct within this suit’s scope. The practical effect is that this patent cannot be used again against Google in district court. However, the public record does not disclose whether a licensing payment or other consideration was exchanged — the stipulation alone is neutral as to whether Mobile Health received commercial value.
No further claims vs. GoogleGoogle’s defenses dismissed without prejudice — validity challenge preserved
The asymmetric structure of this stipulation is strategically notable. Google’s defenses — which likely included invalidity, non-infringement, and potentially inequitable conduct — were dismissed without prejudice. This preserves Google’s ability to challenge US11468984B2 at the USPTO via IPR or ex parte reexamination, or to assert invalidity defenses if the patent is asserted against other Google products or in a fresh action by a different plaintiff or successor entity.
IPR / invalidity path preservedThe wearable health patent remains enforceable against third parties
Dismissal with prejudice binds only the parties to this litigation. US11468984B2 remains valid and enforceable against all other wearable device manufacturers — Apple Watch, Samsung Galaxy Watch, Fitbit, Garmin, and others operate under full litigation risk from this patent. Companies active in continuous health monitoring, biometric sensing, or wearable OS development should treat this patent as active enforcement risk despite the Google case closure.
Patent active vs. all othersFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Mobile Health Innovative Solutions, LLC | Company | Wearable health monitoring patent assertion entity — holder of US11468984B2Search in Eureka ↗ |
| Defendant | Google, LLC | Company | Google, LLC — developer and manufacturer of Google Pixel Watch wearable devicesSearch in Eureka ↗ |
| Plaintiff counsel | Randall T. Garteiser | Attorney | Counsel for Mobile Health Innovative Solutions, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Rene A. Vazquez | Attorney | Counsel for Mobile Health Innovative Solutions, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PLLC | Law Firm | Representing Mobile Health Innovative Solutions, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Sinergia Technology Law Group, PLLC | Law Firm | Representing Mobile Health Innovative Solutions, LLCSearch in Eureka ↗ |
| Defendant counsel | Daniele San Roman | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Evan Matthew McLean | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Gurneet Singh | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Israel Sasha Mayergoyz | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Michael E. Jones | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Shaun William Hassett | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Tharan Gregory Lanier | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant counsel | Tracy Ann Stitt | Attorney | Counsel for Google, LLCSearch in Eureka ↗ |
| Defendant law firm | Jones Day | Law Firm | Representing Google, LLCSearch in Eureka ↗ |
| Defendant law firm | Jones Day (Chicago) | Law Firm | Representing Google, LLCSearch in Eureka ↗ |
| Defendant law firm | Jones Day (Cleveland) | Law Firm | Representing Google, LLCSearch in Eureka ↗ |
| Defendant law firm | Jones Day (Palo Alto) | Law Firm | Representing Google, LLCSearch in Eureka ↗ |
| Defendant law firm | Potter Minton PC | Law Firm | Representing Google, LLCSearch in Eureka ↗ |
| Presiding judge | Judge Rodney Gilstrap | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The Court’s order accepts the joint stipulation verbatim, confirming the with-prejudice dismissal of all plaintiff claims and the without-prejudice dismissal of defendant’s defenses. The asymmetric framing — plaintiff permanently barred, defendant fully preserved — is a deliberate negotiating outcome, not a default. The denial of all pending relief as moot confirms no substantive rulings were made on infringement or validity, leaving US11468984B2’s legal strength unresolved on the merits.
US11468984B2 — wearable health monitoring technology
US11468984B2, filed under application number US16/850984, covers technology in the wearable health monitoring space. The patent’s assertion against Google Pixel Watch — a device integrating continuous heart rate monitoring, ECG functionality, body temperature sensing, and health alert systems — suggests the claims are directed at hardware-software integration within wrist-worn health wearables. The patent designation B2 confirms it issued with amended claims following USPTO examination, which may indicate narrowing from the original application scope.
Wearable health monitoring has become one of the most contested patent domains in consumer electronics, driven by Apple, Google, Samsung, Garmin, and Fitbit competing in continuous biometric sensing. A patent covering core health monitoring functions on wrist-worn devices carries substantial licensing leverage against any OEM shipping a smartwatch with health features. The fact that Mobile Health chose to assert this patent against Google’s flagship Pixel Watch line — defended by Jones Day across multiple offices — signals that the plaintiff believed the claims had meaningful infringement coverage over real commercial products.
Should you run an FTO against US11468984B2?
Any company developing or shipping wearable devices with continuous health monitoring, biometric sensing, or integrated alert systems should treat US11468984B2 as an active FTO risk. The dismissal with prejudice applies only to Google. Apple Watch, Samsung Galaxy Watch, Garmin, Fitbit/Google’s Fitbit line under separate product configurations, and emerging health wearable startups remain fully exposed to assertion. Given the active enforcement posture evidenced by this E.D. Texas filing, an FTO analysis prior to product launch or major feature expansion is commercially prudent.
PatSnap Eureka’s FTO Search Agent allows R&D and IP teams to map US11468984B2’s claim scope against their own wearable product architectures, identify design-around opportunities, and surface prior art that could support an IPR petition if the patent is asserted. Eureka’s claim charting and litigation history features also allow you to cross-reference how Mobile Health has construed similar claims in this and any future filings — giving product and legal teams early warning before a demand letter arrives.
Run a freedom-to-operate analysis on US11468984B2 to assess your product’s exposure
Run FTO in Eureka →Similar wearable health patent cases in E.D. Texas
Explore related patent infringement actions asserting wearable health monitoring technology before Judge Gilstrap and across the Eastern District of Texas.
What this case signals for the wearable health IP landscape
A fast, with-prejudice dismissal in E.D. Texas against a Big Tech defendant rarely happens without commercial context. Here is what it means.
E.D. Texas remains the venue of choice for wearable health NPE filings
Judge Gilstrap’s docket and plaintiff-friendly local rules continue to attract health-tech NPE plaintiffs. The speed of this resolution — 261 days to stipulated dismissal — does not diminish Texas’s strategic appeal; it may reflect the leverage the venue itself creates, accelerating defendant settlement incentives before expensive Markman and discovery phases.
Asymmetric dismissal terms signal structured settlement, not pure capitulation
When plaintiff dismisses with prejudice but defendant’s defenses are explicitly preserved without prejudice, the parties have almost certainly negotiated a license or covenant not to sue with calibrated scope. IP teams at wearable device companies should treat this structure as a signal to audit their own exposure to US11468984B2 before Mobile Health targets their products next.
Mobile v Google — key questions answered
Mobile Health Innovative Solutions, LLC filed a patent infringement action against Google, LLC on June 11, 2024, in the Eastern District of Texas, asserting US11468984B2 against Google Pixel Watch products. The case was dismissed with prejudice via joint stipulation on February 27, 2025, after 261 days. Each party bore its own costs and fees.
A dismissal with prejudice under Rule 41 functions as a final judgment on the merits. Mobile Health permanently loses the right to re-assert US11468984B2 against Google for any conduct raised or that could have been raised in this lawsuit. The patent remains enforceable against all other parties not named in this action.
The asymmetric dismissal terms reflect a negotiated outcome. By preserving Google’s defenses without prejudice, Google retains the ability to challenge US11468984B2’s validity at the USPTO via IPR or in future litigation. This structure is consistent with a license or covenant-not-to-sue agreement where Google secured some protection but did not concede the patent’s validity.
No. The dismissal with prejudice binds only the parties — Mobile Health and Google. US11468984B2 remains valid, enforceable, and assertable against Apple, Samsung, Garmin, Fitbit, and any other wearable device manufacturer. Companies in the wearable health monitoring space should conduct independent FTO analysis on this patent.
Mobile Health was represented by Garteiser Honea PLLC and Sinergia Technology Law Group, PLLC. Google was represented by Jones Day (across its Dallas, Chicago, Palo Alto, and Cleveland offices) and Potter Minton PC, reflecting a well-resourced defence team typical of Big Tech patent litigation strategy in E.D. Texas.
PatSnap Eureka searches patents and litigation data to answer instantly.